Cholera: Clinical Trials

17 trials for Cholera, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 unknown, 1 recruiting. 17 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 317Completed 12, Unknown 4, Recruiting 1
Phase 21Completed 1

Follow Cholera: new trials by email Literature Review of Cholera trials Research Report on Cholera

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Co-administration Study of OCV, TCV and MR
Oral Cholera Vaccine (OCV), Typhoid Conjugate Vaccine (TCV), Measles and Rubella (MR) - Typhoid, Cholera
Phase 3UnknownInternational Centre for Diarrhoeal Disease Research, Bangladesh21172023-10-142023-10-13
Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea
Next Generation ORS (oral rehydration solution) (including placebo, Current standard control ORS (oral rehydration solution) - Diarrhea, Cholera
Phase 2 / Phase 3CompletedUniversity of Florida3962023-08-212026-04-14
To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)
Hillchol vaccine - Cholera
Phase 3UnknownBharat Biotech International Limited18002023-02-042023-02-17
A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131).
Hillchol vaccine, Shanchol Vaccine - Cholera
Phase 3UnknownBharat Biotech International Limited18002022-02-222022-08-18
Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™
Oral Cholera Vaccine Simplified (OCV-S), Shanchol™ - Cholera
Phase 3CompletedInternational Vaccine Institute25302021-10-062023-06-22
Management of Shock in Children With SAM or Severe Underweight and Diarrhea
Blood and Dopamine, Blood and adrenaline - Shock Hypovolemic, Shock, Septic
Phase 3RecruitingInternational Centre for Diarrhoeal Disease Research, Bangladesh1352021-08-172025-04-16
Safety and Immunogenicity of a New Formulation of Euvichol®
Test Oral Cholera Vaccine, Euvichol® - Cholera
Phase 3UnknownInternational Vaccine Institute4422016-03-012015-12-17
A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic
Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell - Cholera
Phase 3CompletedSanofi Pasteur, a Sanofi Company3362015-04-012018-03-26
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
PXVX0200, Placebo - Cholera
Phase 3CompletedBavarian Nordic3982014-05-012023-06-28
A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults
PXVX0200 Lot A, PXVX0200 Lot B, PXVX0200 Lot C - Cholera
Phase 3CompletedBavarian Nordic31462014-05-012023-06-28
Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera
PXVX0200, placebo - Cholera
Phase 3CompletedBavarian Nordic1972013-09-012023-06-28
Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh
Shanchol, Placebo - Cholera
Phase 3CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh2044382012-12-092018-03-20
Ciprofloxacin Multiple Dose for Adult Cholera
Ciprofloxacin, Azithromycin - Cholera
Phase 3CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh2182007-07-012011-07-12
Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata
bivalent killed whole cell oral cholera vaccine, Placebo - Diarrhea, Cholera
Phase 3CompletedInternational Vaccine Institute693292006-07-012014-07-31
Single Dose Azithromycin in the Treatment of Adult Cholera
Azithromycin - Cholera
Phase 3CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh2202002-12-012006-07-21
Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial
Ciprofloxacin - Cholera
Phase 3CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh1802001-05-012022-02-11
Zinc Supplementation in Cholera Patients
Zinc - Cholera
Phase 3CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh2000-11-012005-10-20

Narrower conditions

Diarrhea (2)  ·  Measles (1)  ·  Rubella (1)  ·  Severe Acute Malnutrition (1)  ·  Shock (1)  ·  Shock, Septic (1)  ·  Thinness (1)  ·  Typhoid Fever (1)  ·  Vibrio Infections (1)

Broader conditions

Bacterial Infections (17)  ·  Bacterial Infections and Mycoses (17)  ·  Gram-Negative Bacterial Infections (17)  ·  Infections (17)  ·  Vibrio Infections (16)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Signs and Symptoms, Digestive (2)  ·  Body Weight (1)  ·  Enterobacteriaceae Infections (1)  ·  Inflammation (1)  ·  Malnutrition (1)  ·  Mononegavirales Infections (1)  ·  Morbillivirus Infections (1)  ·  Nutrition Disorders (1)

Interventions

shanchol (3)  ·  Azithromycin (2)  ·  Ciprofloxacin (2)  ·  Blood Specimen Collection (1)  ·  Calcium (1)  ·  Cholera Vaccines (1)  ·  Dopamine (1)  ·  Epinephrine (1)  ·  World Health Organization oral rehydration solution (1)  ·  Zinc (1)

Sponsors

International Centre for Diarrhoeal Disease Research, Bangladesh (7)  ·  Bavarian Nordic (3)  ·  International Vaccine Institute (3)  ·  Bharat Biotech International Limited (2)  ·  Sanofi Pasteur, a Sanofi Company (1)  ·  University of Florida (1)

Countries

Bangladesh (7)  ·  India (3)  ·  United States (3)  ·  Australia (1)  ·  Dominican Republic (1)  ·  Nepal (1)

Top investigators

James McCarty, MD (3)  ·  Debasish Saha, MBBS,MS (2)  ·  Dipika Sur, MD (1)  ·  Julia Lynch, MD (1)  ·  Laura Digilio, MD (1)  ·  Md Taufiqul Islam, MBBS, MPH (1)  ·  Sam Cheng, MD. PhD (1)  ·  Swapan K Roy, MBBS,MSc,Phd (1)  ·  Tahmeed Ahmed, PhD (1)  ·  Wasif A Khan, MBBS, MS (1)

Results publications

PMID 10371570, PMID 16182896, PMID 1632474, PMID 16760445, PMID 18184631, PMID 19593244, PMID 19761838, PMID 19819004, PMID 21615299, PMID 21627690, PMID 21907255, PMID 22028938, PMID 23362293, PMID 23496872, PMID 24161413, PMID 24196006, PMID 24661049, PMID 26323041, PMID 26440279, PMID 27001804, PMID 27144848, PMID 27622507, PMID 27673385, PMID 28144779, PMID 28316439, PMID 28509730, PMID 28566334, PMID 29317118, PMID 29318195, PMID 29463233, PMID 29470934, PMID 29550406, PMID 29624592, PMID 29655627, PMID 29895500, PMID 30065491, PMID 30772070, PMID 31092224, PMID 31743334, PMID 31821418, PMID 31879124, PMID 32032273, PMID 37045565, PMID 38023545, PMID 38614631, PMID 8194289, PMID 9842034

NIH funding

R21AI169282 (1)